Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [8]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [2]
        • LPEP Programme
        • PEP++ project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
    • PEP4LEP 2.0 & PEP4LEP [1]
      • PEP4LEP project
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Leprosy in posteradication era – A clinicopathological correlation: How far we have achieved?

Deepti Gangwar , Amitosh Mishra , Sara Siddiqui , et al. Nepal Journals Online (JOL). Asian Journal of Medical Sciences. 2022; 13 (12) : 144-148.
Download PDF
Publication

Utility of a Mycobacterium leprae molecular viability assay for clinical leprosy: An analysis of cases from the Philippines, Ethiopia, and Nepal

Lenz SM, Ray NA, Lema T, et al. Frontiers Media SA. Frontiers in Tropical Diseases. 2022;
Download PDF
Publication

Assessing the Quality of the World Health Organization's Skin NTDs App as a Training Tool in Ghana and Kenya: Protocol for a Cross-sectional Study.

Frej A, Cano M, Ruiz-Postigo J, et al. JMIR research protocols. 2022; 11 (12) : e39393.
Download PDF
Publication

Diagnosis of New Leprosy Patients through Various Histological Findings according to Biopsy Sites

Song S, Lim J, Park S, et al. Korean Dermatological Association and The Korean Society for Investigative Dermatology. Annals of Dermatology. 2022;
Download PDF
Publication

Solitary plaque of borderline lepromatous leprosy clinically masquerading as paucibacillary leprosy

Gurjar R, Khullar G, Dewan K, et al. SAGE Publications. Tropical Doctor. 2022;
Publication

Editorial: Leprosy reactions: New knowledge on pathophysiology, diagnosis, treatment and prevention

Pinheiro RO, Rosa PS, Spencer JS, et al. Frontiers Media SA. Frontiers in Medicine. 2022;
Download PDF
Publication

Role of molecular approaches to distinguish post kala-azar dermal leishmaniasis from leprosy: A case study

Roy S, Roy M, Nath S, et al. Scientific Scholar. Indian Journal of Dermatology, Venereology and Leprology. 2022;
Download PDF
Publication

Definition of symptoms guide for suspect case identification

Government of Telangana , National Leprosy Eradication Programme , NLEP LCDC , et al. 2022;
Download PDF
Publication

Leprosy – Old wine in new bottle Leprosy

Adithyan P, Raghavendra BN, Patra AK. Our Dermatology Online. 2022;
Download PDF
Publication

Tropical Diseases in Women

Pradhan S, Mishra A, Sahu K. Springer Nature Singapore. Skin Diseases in Females. 2022;

Pagination

  • Previous page ‹‹
  • Page 74
  • Next page ››
Subscribe to Diagnosis

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2026 InfoNTD